Role of anthracycline and comprehensive geriatric assessment for elderly patients with diffuse large B-cell lymphoma
Author:
Affiliation:
1. Memorial Sloan Kettering Cancer Center, New York, NY;
2. Winship Cancer Institute, Emory University, Atlanta, GA; and
3. Laura and Isaac Perlmutter Cancer Center, New York University School of Medicine, New York, NY
Abstract
Publisher
American Society of Hematology
Subject
Cell Biology,Hematology,Immunology,Biochemistry
Link
http://ashpublications.org/blood/article-pdf/130/20/2180/1403319/blood736975.pdf
Reference48 articles.
1. The importance of age in survival of patients treated with chemotherapy for aggressive non-Hodgkin’s lymphoma;Vose;J Clin Oncol,1988
2. A predictive model for aggressive non-Hodgkin’s lymphoma;International Non-Hodgkin’s Lymphoma Prognostic Factors Project;N Engl J Med,1993
3. The proportion of activated B-cell like subtype among de novo diffuse large B-cell lymphoma increases with age;Mareschal;Haematologica,2011
4. How I treat elderly patients with diffuse large B-cell lymphoma;Pfreundschuh;Blood,2010
5. Treatment of the elderly patient with diffuse large B cell lymphoma;Fields;Br J Haematol,2012
Cited by 40 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Challenges identifying DLBCL patients with poor outcomes to upfront chemoimmunotherapy and its impact on frontline clinical trials;Leukemia & Lymphoma;2024-01-05
2. Hodgkin lymphoma treatment for older persons in the modern era;Hematology;2023-12-08
3. Lenalidomide plus rituximab for the initial treatment of frail older patients with DLBCL: the FIL_ReRi phase 2 study;Blood;2023-10-26
4. Reduced-Intensity Anthracycline-Free Chemoimmunotherapy in Elderly Patients With Newly Diagnosed or Relapsed Diffuse Large B-Cell Lymphoma;Journal of Hematology;2023-08
5. Utility of the frailty score for predicting prognosis and individualizing treatment intensity in elderly patients with diffuse large B cell lymphoma;Annals of Hematology;2023-04-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3